Anna Dominiczak
Anna Dominiczak is a Polish-born British medical researcher and academic specializing in cardiovascular disease and genetics. She is currently the Regius Professor of Medicine at the University of Glasgow, and is one of the leading figures in the field of hypertension research.
Early Life and Education[edit | edit source]
Dominiczak was born in Poland and completed her early education there. She moved to the United Kingdom for her higher studies. She earned her MBChB degree from the University of Glasgow and later completed her MD degree from the same institution.
Career[edit | edit source]
Dominiczak started her career as a physician and later moved into medical research. She has made significant contributions to the field of cardiovascular disease, particularly in the area of hypertension. Her research has focused on the genetic causes of hypertension and the development of new treatments for the condition.
In 2016, Dominiczak was appointed as the Regius Professor of Medicine at the University of Glasgow, becoming the first woman to hold this prestigious position. She is also the head of the College of Medical, Veterinary and Life Sciences at the university.
Research and Contributions[edit | edit source]
Dominiczak's research has significantly advanced our understanding of the genetic causes of hypertension. She has published numerous peer-reviewed articles in prestigious medical journals and has been cited extensively for her work. Her research has also led to the development of new treatments for hypertension, improving the lives of patients around the world.
Honours and Awards[edit | edit source]
In recognition of her contributions to medicine and medical research, Dominiczak has received numerous awards and honours. She is a Fellow of the Royal Society of Edinburgh and the Academy of Medical Sciences. In 2016, she was awarded the prestigious Queen's Birthday Honour for her services to medicine.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
